I do agree with @8horse that the valuation is cheap.
However I don't agree with the long-term strategy of Sigma of growth via M&A.
PS: I have been approached by Sigma rep in a few different pharmacies. They are now trying to win over independent pharmacies with attractive discount (more than what EBO & API offered me). Ie, SIG IMO is desperate for growth, with willingness to compromise on profit margins, which is a down for me.
Ann: Change of Director's Interest Notice, page-79
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SIG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.78 |
Change
0.080(2.96%) |
Mkt cap ! $2.300B | |||
| Open | High | Low | Value | Volume |
| $2.74 | $2.93 | $2.74 | $37.80M | 13.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 167207 | $2.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.79 | 246261 | 9 |
View Market Depth
| Last trade - 16.10pm 28/11/2024 (20 minute delay) ? |
| SIG (ASX) Chart |
